The role of sentinel node mapping in endometrial cancer
DOI:
https://doi.org/10.47464/MetroCiencia/vol30/2/2022/7-9Keywords:
mapeo de ganglio centinela, cáncer endometrial, linfadenectomía pélvicaAbstract
In 2017, it was estimated that in developed countries such as the United States, around 61,380 cases of endometrial cancer were diagnosed, of which 10,920 died1. 4% of women with endometrial cancer are under 40 years of age and more than 70% are nulliparous at the time of diagnosis, due to the fact that motherhood has been delayed in recent years. 80% of endometrial cancer cases are diagnosed in early stages (stage I), with a survival rate of over 80% at 5 years, and only 10% of all cases are considered family inheritance.
Downloads
References
Moore K, Brewer MA. Endometrial Cancer: Is This a New Disease? American Society of Clinical Oncology. 2017.
Trojano G, Olivieri C, Tinelli R, Damiani GR, Pellegrino A, Cicinelli E. Conservative treatment in early stage endometrial cancer: a review. Acta Biomed. 2019.
Brooks R, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, et al. Current Recommendations and Recent Progress in Endometrial Cancer. CA CANCER J CLIN. 2019.
Gezer S, Duman Öztürk S, Hekimsoy T, Vural Ç, İşgören S, Yücesoy İ, et al. Cervical versus endometrial injection for sentinel lymph node detection in endometrial cancer: a randomized clinical trial. Int J Gynecol Cancer. 2020.
Jijón A, Román E. El rol del mapeo de ganglio centinela en el cáncer endometrial: Reporte de caso. 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Alejandro Merino Vaca
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
